期刊文献+

老年稳定型冠心病患者B型利钠肽分层随访5年结果 被引量:3

Results of five-year follow-up for hospitalization events according to level of B-type natriuretic peptide in aged patients with stable coronary heart disease
暂未订购
导出
摘要 目的:探讨稳定型冠心病(SCHD)患者静脉血浆B型利钠肽(BNP)水平与中远期住院事件的关系。方法:入选88例老年SCHD患者,均经冠脉造影(CAG)证实。按所测定的静脉BNP浓度分为BNP≥108pg/ml组(44例)和BNP<108pg/ml组(44例)。随访两组5年的死亡、非致死性ACS、再次PCI等心血管原因和非心血管原因住院事件,并进行比较。结果:平均随访62.7月,高水平BNP组的全因住院事件率显著高于低水平BNP组[62.1%(141/227)比37.9%(86/227),P=0.041],非心血管原因住院率非常显著高于低水平BNP组[39.2%(89/227)比16.3%(37/227),P=0.010]。结论:老年稳定型冠心病中基线B型利钠肽水平较高者的远期住院事件率较高。 Objective: To explore relationship between venous plasma level of B type natriuretic peptide (BNP) and medium-long term hospitalization events in aged patients with stable coronary heart disease (SCHD). Methods: A total of 88 aged SCHD patients proved by coronary angiography (CAG) were enrolled. According to their venous BNP concentrations, they were divided into BNP≥108pg/ml group (n = 44) and BNP〈108pg/ml group (n = 44). Rates of hospitalization events within five years, including cardiovascular-cause hospitalization (death, nonfatal a- cute coronary syndrome, second percutaneous coronary intervention) and non cardiovascular-cause hospitalization, were followed up. Results: After a mean 62.7 months follow-up, rate of all-cause hospitalization events of high BNP level group [62.1% (141/227)] were significantly higher than that of low BNP level group [37.9% (86/ 227), P = 0. 041], especially rates of non cardiovascular-cause hospitalization events [39.2% (89/227) vs. 16.3% (37/227), P = 0. 010]. Conclusion: Rates of medium-long term hospitalization events are higher in aged patients with stable coronary heart disease who have high baseline level of B type natriuretic peptide.
出处 《心血管康复医学杂志》 CAS 2013年第5期454-457,共4页 Chinese Journal of Cardiovascular Rehabilitation Medicine
基金 上海市浦东新区卫生局重点协作项目(PW2010D-9)
关键词 冠状动脉疾病 利钠肽 住院 Coronary artery disease Natriuretic peptide, brain Hospitalization
  • 相关文献

参考文献10

  • 1Mukoyama M, Nakao K, Saito Y, et al. Human brain natriuretic peptide, a novel cardiac hormone [J]. Lancet, 1990, 335 (8692): 801-802.
  • 2Lyngbaek S, Winkel P, Gotze JP, et al. Risk stratification in stable coronary artery disease is possible at cardiac troponin levels below conventional detection and is improved by use of N-termi- nal pro-B-type natriuretic peptide [J]. Eur J Prey Cardiol, 2013.
  • 3Windhausen F, Hirsch A, Sanders GT, et al. N-terminal pro- brain natriuretic peptide for additional risk strati{ication in pa- tients with non-ST-elevation acute coronary syndrome and an ele- vated troponin T: an Invasive versus Conservative Treatment in Unstable coronary Syndromes (ICTUS) substudy [J]. Am Heart J, 2007, 153 (4): 485-492.
  • 4殷兆芳,方唯一,任义荣,严毓勤,解玉水,许左隽,顾爱春,黄震华,吴士尧.冠心病患者动静脉血浆B型利钠肽浓度变化及其意义[J].心血管康复医学杂志,2009,18(1):44-46. 被引量:5
  • 5殷兆芳,方唯一,任义荣,许左隽,史春志,顾爱春,解玉水,黄震华,严毓勤,吴士尧.药物洗脱支架对稳定冠心病患者血浆B型脑利钠肽的影响[J].心血管康复医学杂志,2010,19(1):54-57. 被引量:2
  • 6de Lemos JA, McGuire DK, Drazner MH. B-type natriuretic peptide in cardiovascular disease [J]. Lancet, 2003, 362 (9380): 316-322.
  • 7殷兆芳,方唯一,吴士尧,严毓勤,任义荣,解玉水.老年稳定性冠心病患者血浆B型利钠肽分层随访1年结果[J].实用老年医学,2010,24(1):33-36. 被引量:6
  • 8Hama N, Itoh H, Shirakami G, et al. Rapid ventricular induc- tion of brain natriuretic peptide gene expression in experimental acute myocardial infarction [J]. Circulation, 1995, 92 (6) : 1558-1564.
  • 9Saenger AK, Jaffe AS. The use of biomarkers for the evaluation and treatment of patients with acute coronary syndromes [J]. MedClinNorthAm, 2007, 91 (4): 657-681.
  • 10Kragelund C, Gronning B, Omland T, et al. Is N terminal pro B-type natriuretic peptide (NT-proBNP) a useful screening test for angiographic findings in patients with stable coronary disease [J]. AmHeart J, 2006, 151 (3): 712. e1-712, e7.

二级参考文献31

  • 1任节,段宝祥,毛建华.脑钠肽与心力衰竭[J].心血管康复医学杂志,2005,14(1):78-80. 被引量:19
  • 2胡坚,尹绢,邓荣春,宁芳,尹秋林,邱元芝.急性冠脉综合征病人的血浆脑钠肽及C反应蛋白检测意义[J].实用老年医学,2007,21(2):101-103. 被引量:9
  • 3Windhausen F, Hirsch A, Sanders GT, et al. N--terminal pro-brain natriuretic peptide for additional risk stratification in patients with non-ST-elevation acute coronary syndrome and an elevated troponin T: an invaslve versus conservative treatment in unstable coronary syndromes (ICTUS) substudy [ J]. Am Heart J, 2007, 153 (4), 450-453.
  • 4Saenger AK, Jaffe AS. The use of biomarkers for the evaluation and treatment of patients with acute coronary syndromes [J]. Med Clin North Am, 2007, 91 (4):657--681.
  • 5Shlipak MG, Ix JH, Bibbins-Domingo K, et al. Biomarkers to predict recurrent cardiovascular disease:the heart and soul study [J]. Am J Med, 2008, 121 (1): 50--57.
  • 6Palazzuoli A, Deckers J, Calabro A. Brain natriuretic peptide and other risk markers for outcome assessment in patients with non-ST-elevation coronary syndromes and preserved systolic function [J].Am J Cardiol, 2006, 98 (10): 1322--1328.
  • 7Morrow DA, de Lemos JA, Sabstilie MS, Evaluation of B-- type natrluretlc peptide for risk assessment in unstable angina/ non-ST-segment elevation myocardial infarction; B-type natriuretie peptide and prognosis in TACTICS--TIMI 18 [J]. J Am CollCardiol, 2003, 41 (8): 1264--1272.
  • 8Sadanandan S, Cannon CP, Chekuri, et al. Association of elevated B--type natriuretic peptide levels with anglographic lindings among patients with unstable angina and non-ST-segment elevation myocardial infarction [J].J Am Coll Cardioh 2004, 44 (3), 564--568.
  • 9Omland T, Persson A, Ng L, et al. N-- terminal pro B-type natriuretic peptide and long-term mortality in acute coronary syn dromes [J]. Circulation, 2002, 106 (23): 2913-2918.
  • 10McClure SJ, Gall S, Schechter CB, at al. Pereutaneous coronary revascularization reduces plasma N--terminal pro-B-type natriuretic peptide concentration in stable coronary artery disease [J]. J Am Coll Cardiol, 2007, 49 (25): 2394--2397.

共引文献10

同被引文献29

引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部